Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

A new gene mutation causes vitamin D resistance and hair loss in two unrelated girls.

A mother and daughter had severe skin, hair, and eye issues linked to IFAP.

Mice with the 'lanceolate hair' mutation have abnormal hair and skin similar to human Netherton's syndrome.

2% Minoxidil does not prevent hair loss during chemotherapy.

DPCP is more effective than tretinoin gel for treating severe alopecia.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Combining SADBE with other treatments can help hair regrowth in alopecia areata patients.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

3% topical minoxidil effectively treats extensive alopecia areata.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Oxidative stress may play a role in causing alopecia areata.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Ebastine may help regrow hair in alopecia areata patients.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

A unique type of lupus panniculitis causes reversible hair loss on the scalp in East Asians.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.